Massive study tracks Real-Life use of new schizophrenia drug KarXT
NCT ID NCT07571148
First seen May 07, 2026 · Last updated May 22, 2026 · Updated 3 times
Summary
This study looks at health records and insurance claims from 6,876 adults with schizophrenia who are taking the medication KarXT. Researchers want to understand who is getting the drug, how it's being prescribed, and whether people stick with it. They will also track hospital visits and any side effects like stomach issues. The goal is to see how KarXT works outside of controlled clinical trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Veradigm
Chicago, Illinois, 60654, United States
Conditions
Explore the condition pages connected to this study.